• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 68 of 100
Herpes Treatment
Health
This Acne Treatment Now Costs Almost $10,000
By Madeline FarberSeptember 21, 2016
Senate Republicans Want Probe of Mylan EpiPen Price Hikes and Rebates
Health
Senate Republicans Want Probe of Mylan EpiPen Price Hikes and Rebates
By ReutersSeptember 21, 2016
The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal
Finance
Bayer Shares Rise After It Ups Sales Targets for Top-Selling Drugs
By ReutersSeptember 20, 2016
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Health
Novartis Says MS Drug Cut Risk of Disability Advance in Study
By ReutersSeptember 17, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Health
A Minnesota Doctor Is Trying Get a $50 EpiPen Alternative to Market
By Sy MukherjeeSeptember 15, 2016
Meet the Federal Government’s Pot Dealer
Health
Meet the Federal Government’s Pot Dealer
By Andrew Joseph and STAT NewsSeptember 15, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
Health
Mylan Reportedly Paid Its Executives More Than Bigger Rivals
By Tom Huddleston Jr.September 14, 2016
Mylan EpiPen; epinephrine injection, 0.3 mg
Health
This Vote Could Finally Make a Difference in Crazy Drug Prices
By Sy MukherjeeSeptember 14, 2016
GERMANY-AGRICULTURE-BAYER-MONSANTO-MERGER
Finance
Bayer, Monsanto Agree to Merge in $66 Billion Deal
By Reuters and Fortune EditorsSeptember 14, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Health
Mylan Agrees to Hand Over EpiPen Documents to Congress
By Sy MukherjeeSeptember 13, 2016
General Economy Images In Bangladesh
Health
U.S. Justice Department Subpoenas Taro Over Generic Drug Pricing
By ReutersSeptember 11, 2016
CNBC Events
Health
Allergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By Sy MukherjeeSeptember 6, 2016
One analyst thinks Mylan's EpiPen price hike ties back to its executive incentive plans.
Health
Mylan’s EpiPen Problems Just Got a Whole Lot Worse
By Sy Mukherjee and ReutersSeptember 6, 2016
PillPack
Finance
PillPack Is Raising More Money to Take On Pharmacies
By Dan PrimackSeptember 6, 2016
Biogen Drug Shows Early Promise against Alzheimer’s Disease
Tech
Biogen Drug Shows Early Promise against Alzheimer’s Disease
By David Z. MorrisSeptember 3, 2016
1...
  • 66
  • 67
  • 68
  • 69
  • 70
...100
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
AI
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problemplaceholder alt text
By Eva RoytburgJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.